Effects of estrogen and progesterone on platelet-activating factor acetylhydrolase activity in ovariectomised rats

Artery. 1994;21(4):234-42.

Abstract

Objective: To evaluate the effect of estrogen and progesterone on plasma platelet-activating factor acetylhydrolase (PAF-AH) activity in ovariectomized rats.

Methods: Plasma PAF-AH activity was examined in ovariectomized rats treated with 17 alpha-ethynylestradiol (0.25 mg/kg; 6 days) or medroxyprogesterone (50 mg/kg; 6 days). The intra- and inter-assay coefficients of variation for plasma PAF-AH activity were 2.5% and 4.4%, respectively. Plasma lipoprotein profiles on day 5 were determined with commercially available kits.

Results: Ovariectomized rats showed no significant change in plasma PAF-AH activity over a 14 day period. Estrogen decreased the PAF-AH activity up to 85%, and progesterone increased PAF-AH activity up to 44% in ovariectomized rats. There was a positive correlation between plasma PAF-AH activity and high density lipoprotein cholesterol (r = 0.96, p < 0.001).

Conclusion: These data suggest that estrogen and progesterone exert an effect on plasma PAF-AH activity in ovariectomized rats, possibly via high density lipoprotein cholesterol.

Publication types

  • Comparative Study

MeSH terms

  • 1-Alkyl-2-acetylglycerophosphocholine Esterase
  • Animals
  • Cholesterol / blood
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Ethinyl Estradiol / pharmacology*
  • Female
  • Kinetics
  • Least-Squares Analysis
  • Lipoproteins / blood
  • Medroxyprogesterone / pharmacology*
  • Ovariectomy*
  • Phospholipases A / blood*
  • Phospholipases A / drug effects
  • Rats
  • Rats, Wistar
  • Time Factors
  • Triglycerides / blood

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL
  • Lipoproteins
  • Triglycerides
  • Ethinyl Estradiol
  • Cholesterol
  • Phospholipases A
  • 1-Alkyl-2-acetylglycerophosphocholine Esterase
  • Medroxyprogesterone